Robaxin Pill Identifier: What Does Methocarbamol Look Like?

Methocarbamol is a generic drug manufactured by several pharmaceutical companies under the brand names Robaxin, Carbacot, and Skelex, among others. It is one of the centrally-acting prescription drugs mainly used for treating muscle pain and discomfort, and sometimes lockjaw or tetanus. Methocarbamol falls under a class of drugs called skeletal muscle relaxants and is available in pill or tablet form and as an injectable solution, with the latter being strictly only administered by a medical professional.

Table Of Contents:

• Robaxin Pill Identifier
• Dosage Forms And Strength
• Use Methocarbamol Safely

What Does Methocarbamol Look Like? The pill or tablet version of this drug is available in two strengths, with the lower being 500 mg and the higher one – Methocarbamol 750 mg. Since the drug is manufactured by various companies, the shape and imprints of this drug vary, with some being round and others being oval. Images of different Methocarbamol pills can be found later on in this article.

What Does Methocarbamol Look Like? Methocarbamol Pill Identifier

Methocarbamol pills will vary in appearance depending on their strength and on which pharmaceutical company produced them. Images of and more information about different Robaxin pills in the market can be found below.

Methocarbamol White Round ASC 500 MG

Supplied by ACI Healthcare USA, Inc. and manufactured by DBL Pharmaceuticals. This is a white, 13 mm round tablet with a debossed line and an ‘ASC’ imprint on one side and ‘500’ on the other.

Methocarbamol ASC 750 MG

Also supplied by ACI Healthcare USA, Inc. and manufactured by DBL Pharmaceuticals, Inc. is a white 19mm oval tablet. One side has an ‘ASC’ imprint, and the other has ‘750’ on it.

Methocarbamol 500 MG (Imprint S 225)

Another white, round tablet is the 500 mg medicine supplied by Solco Healthcare U.S., LLC and manufactured by Emcure Pharmaceuticals USA Inc. One side of this tablet is imprinted with ‘S’ and ‘225’, which are separated by a debossed line.

Methocarbamol 750 MG (Imprint S 226)

The 750mg version from Solco Healthcare U.S., LLC and Emcure Pharmaceuticals USA Inc. also has a white color and an oval shape. Imprinted on one side of the tablet is ‘S 226’.

Methocarbamol 500 MG (Imprint H114)

Unlike the other 500mg tablets with a round shape, Camber Pharmaceuticals, Inc.’s 500mg tablet has an oval shape. It has a white color and is 14mm in size. As for the identifiers, one side has an ‘H’ imprint and a debossed line, and the other side has a ‘114’ imprint.

Methocarbamol 750 MG (Imprint H115)

Camber Pharmaceuticals, Inc.’s 750mg version of the drug is almost visually identical to its 500mg version – it’s white in color and has an oval shape. It is slightly larger, though, with a 19mm length. As for the imprints, ‘H’ is imprinted at the center of one side, and the other has the ‘115’.

Methocarbamol 500 MG (Imprint  V4211)

White round V4211 pill with a size of 13 mm is Qualitest Pharmaceuticals Inc.’s 500mg tablet. Imprinted on one side is ‘4211’ and a letter V, which are divided by a debossed line.

Methocarbamol 750 MG (Imprint V4212)

Unlike Qualitest Pharmaceuticals Inc.’s 500mg tablet, the 750mg version is a 19mm, oval-shaped pill with a ‘4212’ imprint on one side and ‘V’ on the other.

Methocarbamol 500 MG (Imprint West-Ward 290)

West-ward Pharmaceutical Corporation’s 500mg tablet is a round, white one with a size of 20mm. One side has the company name ‘West-ward’ and the numbers 290 imprinted on it, while the other only has a debossed line in the middle.

Methocarbamol 750 MG (Imprint West-ward 292)

West-Ward 292 white 750 mg pill from West-ward Pharmaceutical Corporation has an oval shape and a 27 mm length. It also has the company name ‘West-ward’ imprinted on one side, along with the number 292. The other side only has a debossed line in the middle.

Methocarbamol Dosage Forms

Just like other drugs, there exists a safe limit for Methocarbamol dosage depending on one’s age group and what specific condition is being treated. And of course, it is extremely important to follow a doctor’s recommendation regarding the Methocarbamol dosage to be taken so as to avoid Robaxin overdose and understand how long the drug stays in the system.

Unlike other muscle relaxants, Robaxin works on the central nervous system rather than relaxing the muscles directly. As for Methocarbamol dosage forms, the drug typically comes as a tablet or pill and is usually taken 4 times daily when just starting treatment. Administration frequency may be changed depending on the doctor’s evaluation of one’s condition, but 3 to 6 times daily is the most common.

The drug is supplied in Methocarbamol 500 mg and 750 mg tablets, and there is also an intravenous form which is supplied in 1 mL solutions with a strength of 100 mg. Both 500 mg and 750 mg, as well as intravenous form, are often used alongside muscle rest, physical therapy, or other pain relief measures associated with musculoskeletal conditions.

Variables That Affect Dosage Prescription

The medicine has a recommended dosing range of 4 to 6 grams per day, and this drug is usually taken at an interval of 6 hours. As usual, the prescribed dosage will vary from person to person. For instance, a twice-a-day administration of Robaxin’s 500 mg tablet is recommended for people with health conditions such as cirrhosis, a type of liver disease. Other conditions may affect dosage, and the same goes for drug interactions.

The drug injectable solution has a higher dosage recommendation (for each administration) of 1 gram at 8-hour intervals. The maximum dosage per day, however, is lower than the oral form of the drug – there is a 3-gram-per-day policy that health professionals must follow. Additionally, the drug’s injectable form must only be used for a maximum of 3 consecutive days.

How To Use Methocarbamol Safely?

When it comes to the safe use of Robaxin or any other drug, it is crucial to follow the doctor’s prescription. Robaxin is generally used as a short-term treatment, and if it is not used exactly as prescribed, there are serious risks involved. This drug may cause side effects such as dizziness, discoloration of urine, drowsiness, blurred vision, fever, and upset stomach. These side effects are quite common, but if they increase in severity or do not go away, it is best to call a doctor. On the other hand, side effects like rashes and itching are pretty rare, and something that one must immediately tell their doctor about, and force a patient to search for alternatives to the medicine

As for storage, the drug should be kept in a tightly-closed container at room temperature. This drug must not be exposed to extreme heat, and storing it in damp areas such as the bathroom should be avoided.

Lastly, it’s almost unavoidable to miss or forget a dose. With drugs such as Robaxin, missed doses should be taken as soon as one remembers it. However, for instances where a significant amount of time has passed and it is almost time for the next dose schedule, the missed dose should just be skipped to avoid a double dose. Double doses can cause overdose, whereas excessive and more frequent use of the drug may then lead to addiction. If someone is suffering from Robaxin abuse or addiction, know that help is always available.

Page Sources

1. Abd-Elsalam, S., & Elkhalawany, W. (2018, July 24). Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients. From U.S. National Library of Medicine: https://clinicaltrials.gov/ct2/show/NCT02642874
2. MedlinePlus. (2017, August 15). Methocarbamol. From MedlinePlus: https://medlineplus.gov/druginfo/meds/a682579.html
3. National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Cirrhosis. From National Institute of Diabetes and Digestive and Kidney Diseases : https://www.niddk.nih.gov/health-information/liver-disease/cirrhosis
4. Sibrack, J., & Hammer, R. (2021, July). Methocarbamol. Treasure Island: StatPearls Publishing LLC. From https://www.ncbi.nlm.nih.gov/books/NBK565868/
5. Simon, L. (2003, May 1). robaxin® (methocarbamol tablets, USP). From Food and Drug Administration: https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/011011Orig1s070s071lbl.pdf
6. Witenko, C., Moorman-Li, R., Motycka, C., Duane, K., Hincapie-Castillo, J., Leonard, P., & Valaer, C. (2014). Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. P & T : a peer-reviewed journal for formulary management, 427-235.